HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.

Abstract
Chromium and cysteine supplementation can improve glucose metabolism in animal studies. This study examined the hypothesis that a cysteinate complex of chromium is significantly beneficial than either of them in lowering blood glucose and vascular inflammation markers in Zucker diabetic fatty (ZDF) rats. Starting at the age of 6 wk, ZDF rats were supplemented orally (daily gavages for 8 more weeks) with saline-placebo (D) or chromium (400 microg Cr/Kg body weight) as chromium dinicocysteinate (CDNC), chromium dinicotinate (CDN) or chromium picolinate (CP) or equimolar L-cysteine (LC, img/Kg body weight), and fed Purina 5008 diet for 8 wk. ZDF rats of 6 wk age before any supplementations and onset of diabetes were considered as baseline. D rats showed elevated levels of fasting blood glucose, HbA(1), CRP, MCP-1, ICAM-1 and oxidative stress (lipid peroxidation) and lower adiponectin and vitamin C, when compared with baseline rats. In comparison to D group, CDNC group had significantly lower blood glucose, HbA(1), CRP, MCP-1, ICAM-1 and lipid peroxidation and increased vitamin C and adiponectin levels. CDN, CP or LC showed significantly less or no effect on these biomarkers. Only CDNC lowered blood creatinine levels in comparison to D. While CDN and CP had no effect, activation of NFkappaB, Akt and glucose transporter-2 levels were decreased, insulin receptor substrate 1 (IRS-1) activation increased in livers of CDNC-rats. CDNC effect on glycemia, NFkappaB, Akt and IRS-1 in liver was significantly greater compared with LC. Blood chromium levels did not differ between Cr-groups. Exogenous vitamin C supplementation significantly inhibited MCP-1 secretion in U937 monocytes cultured in high-glucose-medium. CDNC is a potent hypoglycemic compound with anti-inflammatory activity apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 and increased IRS-1 activation in livers of type 2 diabetic rats.
AuthorsSushil K Jain, Jennifer L Croad, Thirunavukkarasu Velusamy, Justin L Rains, Rebeca Bull
JournalMolecular nutrition & food research (Mol Nutr Food Res) Vol. 54 Issue 9 Pg. 1371-80 (Sep 2010) ISSN: 1613-4133 [Electronic] Germany
PMID20306473 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adiponectin
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers
  • Coordination Complexes
  • Hypoglycemic Agents
  • Organometallic Compounds
  • chromium dinicocysteinate
  • Chromium
  • Cysteine
  • Ascorbic Acid
Topics
  • Adiponectin (blood)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Ascorbic Acid (blood, metabolism)
  • Biomarkers (blood, metabolism)
  • Cell Line
  • Chromium (administration & dosage, blood)
  • Coordination Complexes (administration & dosage)
  • Cysteine (administration & dosage, analogs & derivatives)
  • Diabetes Mellitus, Type 2 (blood, complications, diet therapy, metabolism)
  • Diabetic Angiopathies (blood, physiopathology, prevention & control)
  • Diabetic Nephropathies (blood, physiopathology, prevention & control)
  • Dietary Supplements
  • Humans
  • Hypoglycemic Agents (administration & dosage)
  • Liver (drug effects, metabolism)
  • Male
  • Monocytes (metabolism)
  • Organometallic Compounds (administration & dosage)
  • Oxidative Stress (drug effects)
  • Random Allocation
  • Rats
  • Rats, Zucker
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: